Clinical trials recruiting in Tehran, Iran

Phase breakdown

Conditions recruiting in Tehran, Iran

Recruiting trials in Tehran, Iran

• DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases
  NCT06555003 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)
  NCT07298564 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 65 Years · Sex: Female
• Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks
  NCT07093138 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female)
• Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye
  NCT06543667 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease
  NCT07572071 · Phase: Phase 1 · Ages: 30 Years to 70 Years · Sex: All (male and female)
• Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
  NCT07423247 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Tehran, Iran?

6 recruiting trials have at least one study site in Tehran, Iran.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.